MRP as a new predictive marker of tamoxifen efficiency in treatment of estrogen receptor-positive breast cancer

被引：4

作者：

Bogush, T. A. ^{[1
]}

Dudko, E. A. ^{[1
]}

Bogush, E. A. ^{[1
]}

Tikhomirov, M. V. ^{[1
]}

Kirsanov, V. Yu. ^{[1
]}

Davydov, M. I. ^{[1
]}

机构：

[1] Russian Acad Med Sci, NN Blokhin Russian Canc Res Ctr, Moscow 115478, Russia

来源：

DOKLADY BIOCHEMISTRY AND BIOPHYSICS | 2010年 / 430卷 / 01期

基金：

俄罗斯基础研究基金会;

关键词：

P-GLYCOPROTEIN; RESISTANCE; CELLS;

D O I：

10.1134/S1607672910010114

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

[No abstract available]

引用

页码：36 / 40

页数：5

共 7 条

[1] A new marker of tamoxifen resistance of estrogen receptor-positive breast cancer [J].

Bogush, E. A. ;

Ravcheeva, A. B. ;

Bogush, T. A. ;

Zabotina, T. N. ;

Kadagidze, Z. G. ;

Davydov, M. I. .

DOKLADY BIOCHEMISTRY AND BIOPHYSICS, 2007, 413 (01) :83-87

[2] INTERACTION OF TAMOXIFEN WITH THE MULTIDRUG-RESISTANCE P-GLYCOPROTEIN [J].

CALLAGHAN, R ;

HIGGINS, CF .

BRITISH JOURNAL OF CANCER, 1995, 71 (02) :294-299

[3] Antiestrogen-resistant human breast cancer cells require activated Protein Kinase B/Akt for growth [J].

Frogne, T ;

Jepsen, JS ;

Larsen, SS ;

Fog, CK ;

Brockdorff, BL ;

Lykkesfeldt, AE .

[4] Downregulation of erbB3 abrogates erbB2-mediated tamoxifen resistance in breast cancer cells [J].

Liu, Bolin ;

Ordonez-Ercan, Dalia ;

Fan, Zeying ;

Edgerton, Susan M. ;

Yang, XiaoHe ;

Thor, Ann D. .

INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (09) :1874-1882

[5] Ras/Raf-1/MAPK Pathway Mediates Response to Tamoxifen but not Chemotherapy in Breast Cancer Patients [J].

McGlynn, Liane M. ;

Kirkegaard, Tove ;

Edwards, Joanne ;

Tovey, Sian ;

Cameron, David ;

Twelves, Chris ;

Bartlett, John M. S. ;

Cooke, Timothy G. .

CLINICAL CANCER RESEARCH, 2009, 15 (04) :1487-1495

[6] ANTIESTROGENS AND STEROID-HORMONES - SUBSTRATES OF THE HUMAN P-GLYCOPROTEIN [J].

RAO, US ;

FINE, RL ;

SCARBOROUGH, GA .

BIOCHEMICAL PHARMACOLOGY, 1994, 48 (02) :287-292

[7] Activation of nuclear factor-κB (NFκB) identifies a high-risk subset of hormone-dependent breast cancers [J].

Zhou, YM ;

Eppenberger-Castori, S ;

Marx, C ;

Yau, C ;

Scott, GK ;

Eppenberger, U ;

Benz, CC .

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2005, 37 (05) :1130-1144

← 1 →